BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27840902)

  • 1. Identification of a novel alternative splicing transcript variant of the suppressor of fused: Relationship with lymph node metastasis in pancreatic ductal adenocarcinoma.
    Xu Q; Gao J; Li Z
    Int J Oncol; 2016 Dec; 49(6):2611-2619. PubMed ID: 27840902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell.
    Kasai K; Inaguma S; Yoneyama A; Yoshikawa K; Ikeda H
    Cancer Res; 2008 Oct; 68(19):7723-9. PubMed ID: 18829525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
    Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D
    Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.
    Onishi H; Kai M; Odate S; Iwasaki H; Morifuji Y; Ogino T; Morisaki T; Nakashima Y; Katano M
    Cancer Sci; 2011 Jun; 102(6):1144-50. PubMed ID: 21338440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.
    Li J; Hu G; Kong F; Wu K; Song K; He J; Sun W
    Pathol Oncol Res; 2015 Sep; 21(4):1013-20. PubMed ID: 25791566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HNRNPC impedes m
    Huang XT; Li JH; Zhu XX; Huang CS; Gao ZX; Xu QC; Zhao W; Yin XY
    Cancer Lett; 2021 Oct; 518():196-206. PubMed ID: 34271104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer.
    Paradise BD; Gainullin VG; Almada LL; Sigafoos AN; Sen S; Vera RE; Raja Arul GL; Toruner M; Pease DR; Gonzalez AL; Mentucci FM; Grasso DH; Fernandez-Zapico ME
    Biochem J; 2023 Aug; 480(15):1199-1216. PubMed ID: 37477952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of NUMB, APP and VEGFA as the features of pancreatic ductal carcinoma.
    Zheng KL; He TL; Ji WP; Jiang H; Shen Y; Li G; Zhu SB; Tong BL; Zhang YJ
    Int J Clin Exp Pathol; 2015; 8(6):6181-91. PubMed ID: 26261495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer.
    Göhrig A; Detjen KM; Hilfenhaus G; Körner JL; Welzel M; Arsenic R; Schmuck R; Bahra M; Wu JY; Wiedenmann B; Fischer C
    Cancer Res; 2014 Mar; 74(5):1529-40. PubMed ID: 24448236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.
    Hirono S; Yamaue H; Hoshikawa Y; Ina S; Tani M; Kawai M; Ushijima M; Matsuura M; Saiki Y; Saiura A; Yamamoto J; Miki Y; Noda T
    Cancer Sci; 2010 Jan; 101(1):259-66. PubMed ID: 19817750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
    Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5.
    Ji P; Fan X; Ma X; Wang X; Zhang J; Mao Z
    Biochem Biophys Res Commun; 2018 May; 499(4):815-821. PubMed ID: 29621541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.
    Unruh D; Turner K; Srinivasan R; Kocatürk B; Qi X; Chu Z; Aronow BJ; Plas DR; Gallo CA; Kalthoff H; Kirchhofer D; Ruf W; Ahmad SA; Lucas FV; Versteeg HH; Bogdanov VY
    Int J Cancer; 2014 Jan; 134(1):9-20. PubMed ID: 23754313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
    Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
    Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
    Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression.
    Cheng RF; Wang J; Zhang JY; Sun L; Zhao YR; Qiu ZQ; Sun BC; Sun Y
    Chin J Cancer; 2016 Jul; 35(1):64. PubMed ID: 27371108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.